Pharma & Life Sciences
Genome Engineering: CRISPR Frontiers
The 7th Genome Editing Therapeutics Summit is a three-day event focused on advancing genome editing therapies, including in vivo and ex vivo gene editing. It is designed for R&D, preclinical, translational, regulatory, and executive leaders in biopharma and related fields to discuss scientific innovation, safety, clinical efficacy, and regulatory compliance.
The essentials
Event details
- Dates
- August 2026
- Location
- Hilton Boston Logan Airport, United States
- Organiser
- 7th Genome Editing Therapeutics Summit 2026
- Expected attendance
- 23
- Industry
- Pharma & Life Sciences
Agenda themes
Topics covered
- Science & Research
- Education & Training
On stage
Speakers
- Ishani DasguptaSenior Scientist, AbbVie
- Devyn SmithChief Executive Officer, Arbor Biotechnologies
- Gopi ShankerChief Scientific Officer, Beam Therapeutics
- Matthew LaurieSenior Scientist, Bristol Myers Squibb
- Wenning QinSenior Vice President - Research, eGenesis Bio
- John MooreSenior Director - Translational Gene Editing, Eli Lilly
- Birgit SchultesChief Scientific Officer, Intellia Therapeutics
- Alan BrooksSenior Vice President, Research, Metagenomi Therapeutics
- Cindy LiuDirector - Molecular Analytical Development, Prime Medicine
On the floor
Sponsors and partners
- Aldevron
- Broken String Biosciences
- Cirena
- MaxCyte
- Lonza
- Sumitomo Chemical Advanced Medical Solutions America LLC (SC-AMSA)
Plan this event
Work out who to meet here
Luminik sources the attendee picture for an event like Genome Engineering: CRISPR Frontiers, enriches it against your ICP, and sequences it ahead of the date. Capture at the event writes to Salesforce or HubSpot the same day, and attribution ties the pipeline back to the spend.
Spot something wrong on this page? Report a correction and we will fix it.